Does Eating Sugar Cause Diabetes?

There seems to be many misconceptions about how people become diabetic. One is that eating sugar will cause you to have the disease. With as much information as if there is available, one would think that people would by now understand that eating sugar does not “cause” a person to have diabetes. Educating ones self can help put the myths about diabetes out of the picture.

 

There are cases where eating high calorie foods will cause a person to be overweight or even obese, which can contribute to some individuals developing type 2 diabetes, but it is not the actual sugar that is causing it to develop. It is normally the extra weight that is gained when a person is consuming too many sugary foods that are high in calories. Any high calorie foods, whether they are sweetened with sugar or not, can cause weight gain, and the risk of developing type 2 diabetes is raised when a person is overweight.
Knowing the different types of diabetes can also be useful in separating the facts from the myths. Millions of people are diagnosed with some form of the disease every year. The most common type of diabetes is type 2. It is normally diagnosed when a person is middle aged and is not caused by eating sugar, but is many times cause by the person being very overweight. Several different ethnic groups are more prone to being diagnosed with type 2 diabetes, and those include Hispanics, African Americans and some with American Indian heritage.
Another form of diabetes is type 1. This too, has absolutely nothing at all to do with consuming sugar, although most diabetics do have to limit their sugar intake, once diagnosed. Type 1 can be an inherited disease. Many individuals with this type of diabetes are diagnosed when they are children.

 

The last form of diabetes occurs during pregnancy and is called gestational diabetes. It commonly occurs during the last trimester of pregnancy. Many times the woman will not be diabetic after giving birth.

Advances in Type 1 Diabetes Resulting from Human Genome Research

Type 1 Diabetes Kit
Image by Cooking Up A Story via Flickr

Two decades ago those diagnosed with Type 1 diabetes or diabetes mellitus, had little hope of escaping blindness, kidney failure, and possible loss of limbs. Thankfully, health medicine advances and biotech research have provided treatments that allow those with diabetes to live long and productive lives. Advances and information obtained from human genome studies have given health medicine researchers insight into cutting edge drug treatments and prevention technologies.

Human genome research has revealed that Type 1 diabetes is complex and mutations in more than one gene contribute to the likelihood of a person being diagnosed with the disease. Type 1 diabetes causes the body’s immune system to rage against its own pancreas cells and the insulin it produces. This inhibits the body from processing sugars and metabolizing food in a way that is not harmful to the body. The most common treatment is to inject insulin into the body so assist in the performance of these metabolic functions.

By understanding the genomes that are behind the disease, biotech researchers have development insulins that can more effectively treat the disease. New insulins offer diabetics the advantages of fewer injections per day, simpler regimens, and increased blood sugar stabilization. Three examples of insulins derived from DNA or human genome technology are: Aspart, Glargine, and Eli Lilly’s lispro mixture. These drugs vary in how fast or slow they act in the body as well as the type of needle or injector they required. This gives the patients much more choice and ability to work together with their physician to develop a drug therapy that best suits their lifestyle.

Biotech research has also provided insights in how to treat damage caused by the disease. For example, decoding the human genome has led to the development of a protein that blocks the growth of blood vessels in the eyes. A possible gene therapy is being considered to treat diabetic retinopathy which can often lead to blindness.

As human genome research continues to identify missing and/or malfunctioning genes, more possibilities for cutting edge therapy become available for not only Type 1 diabetes but also other diseases.

Enhanced by Zemanta